Opko Health (OPK) EPS (Weighted Average and Diluted) (2010 - 2026)
Opko Health (OPK) reported EPS (Weighted Average and Diluted) of -$0.07 for Q1 2026, up 30.0% on a YoY basis from -$0.05 in Q1 2025, and down 75.0% quarter-over-quarter from -$0.04 in Q4 2025.
Opko Health (OPK) EPS (Weighted Average and Diluted) (2010 - 2026) Analysis & Trends
Opko Health has reported EPS (Weighted Average and Diluted) for 16 years, with the latest figure at -$0.07 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 30.0% year-over-year to -$0.07; the trailing twelve-month figure through Mar 2026 stood at -$0.27 (down 285.71% YoY), and the FY2025 full-year result was -$0.3, down 275.0% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.07, down from -$0.04 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.03 in Q3 2024, with the low at -$0.19 in Q2 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.07 across 5 years, with a median of -$0.08 in 2022.
- Annual changes were most pronounced in 2024 — EPS (Weighted Average and Diluted) surged 127.27% — and 2025, when it slumped 1800.0%.
- Opko Health's EPS (Weighted Average and Diluted) stood at -$0.11 in 2022, then grew by 18.18% to -$0.09 in 2023, then jumped by 111.11% to $0.01 in 2024, then tumbled by 500.0% to -$0.04 in 2025, then slumped by 75.0% to -$0.07 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.07 (Q1 2026), -$0.04 (Q4 2025), and $0.03 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -0.87 |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 4.43 |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.45 |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 3.47 |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 1.20 |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 1.61 |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -0.60 |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 0.87 |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 8.33 |
| 10 | Opko Health | 1.09 Bn | 747.11 Mn | 45.76 Mn | -0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.07 |
| Dec 31, 2025 | -0.04 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | -0.19 |
| Mar 31, 2025 | -0.10 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -0.12 |
| Dec 31, 2023 | -0.09 |
| Sep 30, 2023 | -0.11 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | -0.11 |
| Sep 30, 2022 | -0.11 |
| Jun 30, 2022 | -0.14 |
| Mar 31, 2022 | -0.08 |
| Dec 31, 2021 | -0.11 |
| Sep 30, 2021 | 0.04 |
| Jun 30, 2021 | -0.03 |
| Mar 31, 2021 | 0.05 |